Scientific Advisory Board
Troels Krarup Hansen MD PhD DMSci
Troels Krarup Hansen is professor at the University of Aarhus and Consultant at the Department of Medicine (Endocrinology), Aarhus University Hospital. Troels Krarup Hansen will continue his long-standing interest in diabetes complications, in particular related to the pathophysiological mechanisms underlying diabetic nephropathy. His research is directed towards identification of new markers for the development and maintenance of diabetic complications. Troels Krarup Hansen is therefore well suited to take over the chairmanship of the IDNC Scientific Advisory Board. He has published 130 original papers in international peer-reviewed journals and his H-index is 31. Since May 2016 he is President of the Danish Endocrine Society.
ge
Solomon Tesfaye MB ChB, MD, FRCP
Solomon Tesfaye is a Consultant Physician/Endocrinologist at Sheffield Teaching Hospitals and Honorary Professor of Diabetic Medicine at the University of Sheffield. His research projects include the epidemiology, risk factors, pathogenesis, central nervous system involvement and treatment of diabetic neuropathy and neuropathic pain. He has published a book, over 150 original articles, reviews and book chapters in the field of diabetic neuropathy including a landmark study in the New England Journal of Medicine.
Professor Tesfaye was awarded the Prestigious Camillo Golgi Prize of the European Association for the Study of Diabetes (EASD) in 2014 for major scientific contributions in Diabetic Neuropathy. Professor Tesfaye has had international leadership roles including chairmanship of the International Expert Group on Diabetic Neuropathy that published 7 consensus recommendation papers in 2010/11, and of NEURODIAB (2006-9) which is the largest diabetic neuropathy scientific group in the world. He is also a member of the Science and Research Committee of Diabetes UK; a review panel member for the Medical Research Council, a Board Member of the Global Quantitative Sensation Testing Society; a member of the Advisory Council of the Neuropathy Trust and Secretary of International Insulin Foundation. He is also currently the Associate Editor of Experimental Diabetes Research, Frontiers in Endocrinology, European Endocrinology and Diabetes Management and was previous Associate Editor of Diabetologia. Professor Tesfaye has served as a member of the JDRF, NIDDK, and UK NIHR scientific review panels and as a member of a Diabetes & Neuropathic pain Review Group for the National Institute for Clinical Excellence (NICE).
Paul Fernyhough BSc, PhD
Fernyhough is Professor and Head of the Department of Pharmacology and Therapeutics, University of Manitoba (Canada). He is also Director of the Division of Neurodegenerative Disorders at St Boniface Hospital Research Centre. Fernyhough was born and educated in UK, and performed his B.Sc. degree in Biological Sciences at the University of Essex. Fernyhough performed his PhD in Biochemistry in the Department of Biochemistry (Department of Sir Hans Krebs) at University of Sheffield in the UK. He also performed postdoctoral research at Colorado State University, Kings College London and as a Wellcome Trust Postdoctoral Fellow at St Bartholomew's Medical College (Department of Sir John Vane). All of these positions spanned 1985-1998. Fernyhough subsequently worked for 5½ years (1998-2004) as a fully tenured lecturer in the School of Biological Sciences/Faculty of Life Sciences at the University of Manchester. Fernyhough moved to University of Manitoba in 2004 and his general research interest is in the cell biology underlying neurodegenerative disorders of the peripheral and central nervous systems. Fernyhough is studying the etiology of the peripheral nerve damage observed in patients with diabetes and has identified novel therapeutics that are presently moving through commercialization (phase 1 trials are underway).